Pravastatin improves the impaired nitric oxide-mediated neurogenic and endothelium-dependent relaxation of corpus cavernosum in aged rats

References

• NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83–90
   PubMed Web of Science ®Google Scholar
• Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54–61
   PubMed Web of Science ®Google Scholar
• Corona G, Lee DM, Forti G, et al; EMAS Study Group. Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J Sex Med 2010;7:1362–80
   PubMed Web of Science ®Google Scholar
• Carrier S, Nagaraju P, Morgan DM, et al. Age decreases nitric oxide synthase-containing nerve fibers in the rat penis. J Urol 1997;157:1088–92
   PubMed Web of Science ®Google Scholar
• Johnson JM, Bivalacqua TJ, Lagoda GA, et al. eNOS-uncoupling in age-related erectile dysfunction. Int J Impot Res 2011;23:43–8
   PubMed Web of Science ®Google Scholar
• Musicki B, Kramer MF, Becker RE, Burnett AL. Age-related changes in phosphorylation of endothelial nitric oxide synthase in the rat penis. J Sex Med 2005;2:347–55; discussion 355–7
   Google Scholar
• Jin L, Liu T, Lagoda GA, et al. Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction. FASEB J 2006;20:536–8
   PubMed Web of Science ®Google Scholar
• Gao BH, Zhao ST, Meng FW, et al. Y-27632 improves the erectile dysfunction with ageing in SD rats through adjusting the imbalance between nNO and the Rho-kinase pathways. Andrologia 2007;39:146–50
   PubMed Web of Science ®Google Scholar
• Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004;109:III39–43
   PubMed Web of Science ®Google Scholar
• Nangle MR, Cotter MA, Cameron NE. Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering. Diabetes 2003;52:2396–402
   Google Scholar
• Gokce Mİ, Gülpınar Ö, Öztürk E, et al. Effect of atorvastatin on erectile functions in comparison with regular tadalafil use. A prospective single-blind study. Int Urol Nephrol 2012;44:683–7
   Google Scholar
• Trivedi D, Kirby M, Wellsted DM, et al. Can simvastatin improve erectile function and health-related quality of life in men aged ≥40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971]. BJU Int 2013;111:324–33
   PubMed Web of Science ®Google Scholar
• Mastalir ET, Carvalhal GF, Portal VL. The effect of simvastatin in penile erection: a randomized, double-blind, placebo-controlled clinical trial (Simvastatin treatment for erectile dysfunction-STED TRIAL). Int J Impot Res 2011;23:242–8
   Google Scholar
• Davignon J, Jacob RF, Mason RP. The antioxidant effects of statins. Coron Artery Dis 2004;15:251–8
   PubMed Web of Science ®Google Scholar
• Dobrucki LW, Kalinowski L, Dobrucki IT, Malinski T. Statin stimulated nitric oxide release from endothelium. Med Sci Monit 2001;7:622–7
   PubMedGoogle Scholar
• Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998;97:1129–235
   PubMed Web of Science ®Google Scholar
• Nakata S, Tsutsui M, Shimokawa H, et al. Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway. Arterioscler Thromb Vasc Biol 2007;27:92–8
   PubMed Web of Science ®Google Scholar
• Ohkawara H, Ishibashi T, Saitoh S, et al. Preventive effects of pravastatin on thrombin-triggered vascular responses via Akt/eNOS and RhoA/Rac1 pathways in vivo. Cardiovasc Res 2010;88:492–501
   Google Scholar
• Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 2001;21:1712–9
   PubMed Web of Science ®Google Scholar
• Coelho-Filho OR, De Luca IM, Tanus-Santos JE, et al. Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats. Int J Cardiol 2001;79:215–21
   Google Scholar
• Fontaine D, Fontaine J, Dupont I, et al. Chronic hydroxymethylglutaryl coenzyme A reductase inhibition and endothelial function of the normocholesterolemic rat: comparison with angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol 2002;40:172–80
   Google Scholar
• Kobayashi T, Matsumoto T, Kamata K. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats. Br J Pharmacol 2000;131:231–8
   PubMed Web of Science ®Google Scholar
• Burnett AL. Novel nitric oxide signaling mechanisms regulate the erectile response. Int J Impot Res 2004;16:S15–9
   Web of Science ®Google Scholar
• Andersson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol 2003;170:S6–13; discussion S13–14
   PubMed Web of Science ®Google Scholar
• Rajasekaran M, White S, Baquir A, Wilkes N. Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats. J Androl 2005;26:182–8
   PubMed Web of Science ®Google Scholar
• Numao N, Masuda H, Sakai Y, et al. Roles of attenuated neuronal nitric-oxide synthase protein expression and accelerated arginase activity in impairing neurogenic relaxation of corpus cavernosum in aged rabbits. BJU Int 2007;99:1495–9
   PubMed Web of Science ®Google Scholar
• Park K, Shin JW, Oh JK, et al. Restoration of erectile capacity in normotensive aged rats by modulation of angiotensin receptor type 1. J Androl 2005;26:123–8
   PubMedGoogle Scholar
• Park CS, Ryu SD, Hwang SY. Elevation of intracavernous pressure and NO-cGMP activity by a new herbal Formula in penile tissues of aged and diabetic rats. J Ethnopharmacol 2004;94:85–92
   PubMedGoogle Scholar
• Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003;284:R1–12
   PubMed Web of Science ®Google Scholar
• Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxid production by the protein kinase Akt. Nature 1999;399:597–601
   PubMed Web of Science ®Google Scholar
• Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 2001;299:818–24
   PubMed Web of Science ®Google Scholar
• Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003;83:1325--58
   PubMed Web of Science ®Google Scholar
• Chang S, Hypolite JA, Changolkar A, et al. Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta. Int J Impot Res 2003;15:53–62
   PubMed Web of Science ®Google Scholar
• Ming XF, Viswambharan H, Barandier C, et al. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 2002;22:8467–77
   PubMed Web of Science ®Google Scholar
• Bivalacqua TJ, Champion HC, Usta MF, et al. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci USA 2004;101:9121–6
   PubMed Web of Science ®Google Scholar
• Silva FH, Mónica FZ, Báu FR, et al. Superoxide anion production by NADPH oxidase plays a major role in erectile dysfunction in middle-aged rats: prevention by antioxidant therapy. J Sex Med 2013;10:960–71
   Google Scholar
• Mason RP, Walter MF, Day CA, Jacob RF. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions. Am J Cardiol 2005;96:11F–23F
   PubMed Web of Science ®Google Scholar
• Jorge PA, Osaki MR, de Almeida E. Rapid reversal of endothelial dysfunction in hypercholeterolemic rabbits treated with simvastatin and pravastatin. Clin Exp Pharmacol Physiol 1997;24:948–95
   Google Scholar
• Jorge PA, Almeida EA, Ozaki MR, et al. Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits. Arq Bras Cardiol 2005;84:314–9
   PubMedGoogle Scholar
• Rakotoniaina Z, Guerard P, Lirussi F, et al. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin. Naunyn Schmiedebergs Arch Pharmacol 2006;374:195–206
   PubMed Web of Science ®Google Scholar
• Guerard P, Rakotoniaina Z, Goirand F, et al. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS. Naunyn Schmiedebergs Arch Pharmacol 2006;373:401–14
   PubMed Web of Science ®Google Scholar
• Rao K, Liu JH. Cell apoptosis and male erectile dysfunction. Zhonghua Nan Ke Xue 2008;14:1126–9
   Google Scholar
• Kaneta S, Satoh K, Kano S, et al. All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells. Atherosclerosis 2003;170:237–43
   PubMed Web of Science ®Google Scholar
• de Sotomayor MA, Pérez-Guerrero C, Herrrera MD, et al. Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways. Br J Pharmacol 2005;146:1130–8
   PubMed Web of Science ®Google Scholar
• Li C, Yang CW, Park JH, et al. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. Am J Physiol Renal Physiol 2004;286:F46–57
   PubMed Web of Science ®Google Scholar
• Laufs U, Endres M, Stagliano N, et al. Neuroprotection mediated by changes in the endotelial and cytosketketon. J Clin Invest 2000;106:15–24
   PubMed Web of Science ®Google Scholar
• Wingard CJ, Moukdar F, Prasad RY, et al. Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling. J Sex Med 2009;6:269–78
   Google Scholar
• Park K, Cho SY, Kim SW. Erectile response to type 5 phosphodiesterase inhibitor could be preserved with the addition of simvastatin to conventional insulin treatment in rat model of diabetes. Int J Androl 2011;34:e468–74
   Google Scholar
• Morelli A, Chavalmane AK, Filippi S, et al. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. J Sex Med 2009;6:91–106
   PubMed Web of Science ®Google Scholar